Literature DB >> 27734406

Regulation of IFN-γ Expression.

John Fenimore1, Howard A Young2.   

Abstract

Interferon gamma, referred to here as IFN-γ, is a major component in immunological cell signaling and is a critical regulatory protein for overall immune system function. First discovered in 1965 (Wheelock Science 149: (3681)310-311, 1965), IFN-γ is the only Type II interferon identified. Its expression is both positively and negatively controlled by different factors. In this chapter, we will review the transcriptional and post-transcriptional control of IFN-γ expression. In the transcriptional control part, the regular activators and suppressors are summarized, we will also focus on the epigenetic control, such as chromosome access, DNA methylation, and histone acetylation. The more we learn about the control of this regulatory protein will allow us to apply this knowledge in the future to effectively manipulate IFN-γ expression for the treatment of infections, cancer, inflammation, and autoimmune diseases.

Entities:  

Keywords:  Activator; Epigenetic control; IFN-γ; LncRNA; MicroRNA; Suppressor; Transcriptional control

Mesh:

Substances:

Year:  2016        PMID: 27734406     DOI: 10.1007/978-94-024-0921-5_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Comprehensive network map of interferon gamma signaling.

Authors:  Mohd Younis Bhat; Hitendra S Solanki; Jayshree Advani; Aafaque Ahmad Khan; T S Keshava Prasad; Harsha Gowda; Saravanan Thiyagarajan; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2018-09-06       Impact factor: 5.782

2.  Activation Receptor-Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome.

Authors:  Sytse J Piersma; Melissa A Pak-Wittel; Andrea Lin; Beatrice Plougastel-Douglas; Wayne M Yokoyama
Journal:  J Immunol       Date:  2019-08-23       Impact factor: 5.422

Review 3.  Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.

Authors:  Jerry Vriend; Thomas Klonisch
Journal:  Cell Mol Neurobiol       Date:  2022-07-27       Impact factor: 4.231

4.  Impaired muscle strength is associated with ultrastructure damage in myositis.

Authors:  Andrea Aguilar-Vazquez; Efrain Chavarria-Avila; Mario Salazar-Paramo; Juan Armendariz-Borunda; Guillermo Toriz-González; Marcela Rodríguez-Baeza; Ana Sandoval-Rodriguez; Arisbeth Villanueva-Pérez; Marisol Godínez-Rubí; Jose-David Medina-Preciado; Ingrid Lundberg; Yesenia Lozano-Torres; Cynthia-Alejandra Gomez-Rios; Oscar Pizano-Martinez; Erika-Aurora Martinez-Garcia; Beatriz-Teresita Martin-Marquez; Sergio Duran-Barragan; Brenda-Lucia Palacios-Zárate; Arcelia Llamas-Garcia; Livier Gómez-Limón; Monica Vazquez-Del Mercado
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

5.  Comprehensive Analysis of the Tumor Microenvironment in Cutaneous Melanoma associated with Immune Infiltration.

Authors:  Pan Wang; Xinyu Zhang; Nan Sun; Zhihong Zhao; Jie He
Journal:  J Cancer       Date:  2020-04-06       Impact factor: 4.207

6.  Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes.

Authors:  Beatriz Tavira; Hugo Barcenilla; Jeannette Wahlberg; Peter Achenbach; Johnny Ludvigsson; Rosaura Casas
Journal:  J Diabetes Res       Date:  2018-05-24       Impact factor: 4.011

Review 7.  Predicting Severe Enterovirus 71-Infected Hand, Foot, and Mouth Disease: Cytokines and Chemokines.

Authors:  Weijian Zhang; Zhigang Huang; Mingyuan Huang; Jincheng Zeng
Journal:  Mediators Inflamm       Date:  2020-01-31       Impact factor: 4.711

8.  Effects of IFN-γ on immune cell kinetics during the resolution of acute lung injury.

Authors:  Jason R Mock; Miriya K Tune; Catherine F Dial; Jose Torres-Castillo; Robert S Hagan; Claire M Doerschuk
Journal:  Physiol Rep       Date:  2020-02

9.  The immunologic changes during different phases of intestinal anastomotic healing.

Authors:  Feng Zhang; Song Qiao; Chunqiao Li; Bo Wu; Stefan Reischl; Philipp-Alexander Neumann
Journal:  J Clin Lab Anal       Date:  2020-07-21       Impact factor: 2.352

10.  Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.

Authors:  Guoxu Zheng; Zhangyan Guo; Weimiao Li; Wenjin Xi; Baile Zuo; Rui Zhang; Weihong Wen; An-Gang Yang; Lintao Jia
Journal:  Signal Transduct Target Ther       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.